5-Min Check In: COVID Outpatient Therapies (Remidesivir, Monoclonal Antibodies & Antivirals); Asthma

from 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn · host CommonSpirit Health Physician Enterprise

CommonSpirit Health Physician Enterprise EVP, Dr. Thomas McGinn shares his 5-Minute Check In discussing Omicron updates including currently working outpatient therapies; a Scottish study about Omicron and asthma; the relationship between Epstein-Barr and MS; and several congratulations for recent Enterprise achievements.

Episode metadata supplied by the publisher feed · Published Feb 4, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

5-Min Check In: COVID Outpatient Therapies (Remidesivir, Monoclonal Antibodies & Antivirals); Asthma

0:00 6:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn?

This episode is 6 minutes long.

When was this 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn episode published?

This episode was published on February 4, 2022.

Can I download this 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!